Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression

    ... Myelodysplastic syndromes (MDS) are clonal disorders of hematopoietic stem and progenitor ...

    Research Article last updated 09/13/2017 - 8:25am.

  2. Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R

    ... (NGS) in 179 patients (median age 73 years) with primary myelodysplastic syndromes (MDS); risk distribution according to the revised ...

    Research Article last updated 09/18/2017 - 11:05am.

  3. A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.

    ... landscape of the management of patients with higher-risk myelodysplastic syndromes (HR-MDS). HMAs have improved hematopoiesis and quality of ...

    Research Article last updated 09/11/2017 - 9:04am.

  4. Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints

    ... BACKGROUND: Myelodysplastic syndromes (MDS) are a group of clonal neoplasms characterized by ...

    Research Article last updated 09/11/2017 - 8:59am.

  5. Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation

    ... Myelodysplastic syndromes are a heterogeneous group of clonal hematopoietic stem cell ...

    Research Article last updated 06/22/2015 - 10:15am.

  6. Myelodysplastic Syndromes Treatment (PDQ®): Patient Version

    ... summary has current information about the treatment of myelodysplastic syndromes . It is meant to inform and help patients, families, and ...

    Research Article last updated 12/02/2015 - 9:07am.

  7. Myelodysplastic syndromes

    ... Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by ...

    Research Article last updated 04/16/2014 - 12:04pm.

  8. Relationship between lenalidomide dose modification, duration of therapy, and long-term outcomes in patients with myelodysplastic syndromes

    ... treatment-associated adverse events among patients with myelodysplastic syndromes (MDS) treated with lenalidomide ; such modifications are ...

    Research Article last updated 11/08/2017 - 9:12am.

  9. Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent?

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 10/23/2017 - 11:14am.

  10. New Strategies in Myelodysplastic Syndromes: Application of molecular diagnostics to clinical practice.

    ... complete compendium of recurrently mutated genes in myelodysplastic syndromes (MDS) has been defined, and the application of massively parallel ...

    Research Article last updated 02/04/2013 - 2:55pm.